Tissue infiltration by activated neutrophils occurs in many inflammatory diseases, including rheumatoid arthritis (RA), vasculitis, cystic fibrosis (CF), inflammatory bowel disease and chronic ...

Intermittent fasting may benefit antioxidant and inflammatory markers in postmenopausal women with rheumatoid arthritis.

This review describes the IL-20 family of cytokines in rheumatoid arthritis (RA) and spondyloartrhitits (SpA) including psoriatic arthritis. The IL-20 receptor (R) cytokines IL-19, IL-20, and IL-24 ...

Patients in the intermittent fasting group showed significant decreases in serum malondialdehyde levels and neutrophil-to ... postmenopausal women with rheumatoid arthritis, according to a study ...

Otherwise, neutrophil count was the highest in the control group, the lowest DAS28 score was in the IL-2 group, while the lowest CRP was in the IL-2+TCZ group (P<0.05). (Figure 2) The absolute counts ...

Objectives To identify serious infection (SI) risk by aetiology and site in patients with rheumatoid arthritis (RA) compared with those with non-inflammatory rheumatic and musculoskeletal diseases ...

Methods We performed RNA sequencing of neutrophils from healthy human blood, arthritic blood and arthritic synovial fluid, comparing transcriptional signatures with those from murine K/BxN serum ...

However, under inflammatory conditions like in rheumatoid arthritis (RA), they may start to proliferate, undergo phenotypical changes and become central elements in the perpetuation of inflammation ...

Rheumatoid arthritis is an autoimmune disease that is characterized by inflammation of the joints and the subsequent destruction of cartilage and erosion of the bone. Patients with rheumatoid ...

Nov. 13, 2024 — The use of biologic and targeted therapies for children with juvenile idiopathic arthritis (JIA) surpassed more typical therapies in recent years, according to ...

Objective To investigate the relationship between metabolomic profiles, genome-wide polygenic risk scores (PRSs) and risk of rheumatoid arthritis (RA). Methods 143 nuclear magnetic resonance-based ...

The FDA has started a priority review of Insmed's brensocatib, which is pitching to become the first approved therapy for ...